AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06478810 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Domomedicine and dedicated nursing care for a close and secure monitoring after an ambulatory hepatectomy
Description: For patient who need a minor hepatectomy under laparoscopy for the standard of care, the follow-up will be an ambulatory follow-up. This ambulatory follow-up will be made possible thanks to the integration of Domomedicine and dedicated nursing care for a close and secure monitoring.
Study NCT06276101 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NWRD08 administered by electroporation
Description: DNA plasmid delivered via IM injection + electroporation using TERESA device
Study NCT05784649 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: health education
Description: The health education program will be conducted on the WeChat platform. The contents of health education include 1) knowledge about how to prevent anemia during pregnancy; 2) self-care education videos such as breastfeeding; 3) online courses on how to manage weight during pregnancy, and how to keep good emotions, etc.; 4) Nutrition and lifestyle guidance; 5) knowledge about recognition and prevention of risk factors or diseases: abortion, toxic substances, premature birth. The contents of health education will be totally shared 5 times from 12 weeks to 36 weeks in the pregnancy and once a month on the platform. Every participant should reply read after learning the contents. if they have any questions, they can reply for help for further connection with health professionals.
Study NCT05784649 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: individual counsel
Description: The participants will receive the same health education as the control group. The pregnant women will have one routine checkup a month from 12 weeks to 36 weeks in the hospital. And they will receive counseling with a midwife and a doctor after every routine checkup. The counseling will have a total of 5 times and once a month, 45 minutes per time. The professionals will evaluate health-promoting behaviors such as nutrition and physical activity based on the procedure of the health promotion model. The model includes four continued parts: prior behaviors; personal influences; interpersonal Influences; commitment to a plan of action. Finally, the professionals will give person-centered advice to help the participants practice the content of health education, keep health-promoting behaviors, and achieve a healthy lifestyle.
Study NCT05490134 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saline
Description: 0.15mg/kg bolus of normal saline in 10ml normal saline will be administered via an intravenous (IV) line inserted into the antecubital vein of the non-dominant arm.
Study NCT05610072 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: n-acetylcysteine
Description: Subjects will be randomized to receive 2.4 oral n-acetylcysteine daily.
Study NCT05610072 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Hydromorphone
Description: Subjects will receive up to 192 mg oral hydromorphone daily.
Study NCT05610072 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydromorphone
Description: Subjects will receive up to 192 mg oral hydromorphone daily.
Study NCT05610072 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo n-acetylcystine
Description: Subjects will be randomized to receive placebo n-acetylcysteine daily.
Study NCT05610072 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo hydromorphone
Description: Prior to some experimental sessions, subjects will receive placebo hydromorphone
Study NCT05610072 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo hydromorphone
Description: Prior to some experimental sessions, subjects will receive placebo hydromorphone
Study NCT06193148 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jaktinib
Description: Participants will receive Jaktinib orally for single dose
Study NCT06193148 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will receive Placebo orally for single dose
Study NCT06469697 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: School music broadcast
Description: An arts-based eye health intervention featuring traditional and contemporary music pieces will be broadcasted at both school and community levels.
Study NCT06469697 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Community music broadcast
Description: An arts-based eye health intervention featuring traditional and contemporary music pieces will be broadcasted at community levels.
Study NCT05320068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Vancomycin
Description: A blinded capsule that contains 125mg of vancomycin every 6 hours during 10 days.
Study NCT05320068 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A blinded capsule that contains no vancomycin every 6 hours during 10 days.
Study NCT06358430 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine Phosphate
Description: Given by IV
Study NCT06358430 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given by IV
Study NCT06358430 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Given by IV
Study NCT06358430 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TROP2-CAR-NK Cells
Description: Given by IV
Study NCT06358430 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rimiducid (AP1903)
Description: Given by IV
Study NCT06358430 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lymphodepleting Chemotherapy
Description: Given by Chemotherapy
Study NCT06517173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Y-3 for injection
Description: Qualified subjects were randomly divided into groups in a 1:1 ratio and received continuous treatment with Y-3 injection (40 mg/dose, qd) or placebo control drug. The treatment was performed 10 times for 10 days.
Study NCT06517173 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo control group
Description: Qualified subjects were randomly divided into groups in a 1:1 ratio and received continuous treatment with Y-3 injection (40 mg/dose, qd) or placebo control drug. The treatment was performed 10 times for 10 days.
Study NCT04877444 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Duck Duck Punch
Description: Duck Duck Punch (DDP) is an interactive computer game deliberately designed to enhance UE movement quality via individualized progressive movement practice. DDP is unique as it uses Microsoft Kinect skeletal tracking technology to assess movement performance. The participant sits in front of the Microsoft Kinect and controls a virtual arm with his/her physical arm; reaching forward to punch virtual ducks. The goal 'dose' of DDP will be 200 repetitions.
Study NCT04877444 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: Subjects will perform 15 minutes of aerobic exercise on a recumbent stationary cycle. The target intensity of aerobic exercise is 70% heart rate reserve. Following aerobic exercise subject will play an upper extremity rehabilitation game called Duck Duck Punch.
Study NCT04877444 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lower extremity stretching
Description: Subjects will perform 15 minutes of lower extremity stretching. Following aerobic exercise subject will play an upper extremity rehabilitation game called Duck Duck Punch.
Study NCT05690165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Walking Exercise
Description: Heart rate controlled walking exercise
Study NCT06644222 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: AIRROSTI exercises
Description: Group A will receive AIRROSTI exercises for 45 minutes / one session daily for five days per week
Study NCT06644222 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Thera band exercises
Description: Group B will receive Thera band exercises for 45 minutes/one session per day for five days per week.
Study NCT05993026 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mental health course
Description: The student course involves classroom-based teaching of eight lessons over eight weeks. The aim is to strengthen students' faith in their own abilities (self-efficacy) and ability to understand themselves and others (mentalization). In this way, students become better at entering into positive relationships and communities as well as better at handling everyday challenges both academically and socially. The student course includes teaching, exercises and training in simple tools for mastery and mentalization. The student courses in the classes are handled by staff close to the students and are based on both physical and digital material as well as an app for the students. The employees initially participate in a competency development course.
Study NCT06482177 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Cyclosporine ophthalmic solution
Description: Cyclosporine BID in the study eye
Study NCT05737017 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ClearCoajet
Description: The ClearCoajet is a new hemostasis device with a hybrid function (Coagulation + Injection) and is developed to provide effective coagulation, injection, and marking around lesions without changing devices during the endoscopic procedure.
Study NCT05737017 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ClearCoajet
Description: The ClearCoajet is a new hemostasis device with a hybrid function (Coagulation + Injection) and is developed to provide effective coagulation, injection, and marking around lesions without changing devices during the endoscopic procedure.
Study NCT06390761 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: All acupoints were selected based on traditional Chinese medicine theory and previous articles on PD and constipation.
Study NCT06390761 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Acupuncture
Description: All acupoints were selected based on traditional Chinese medicine theory and previous articles on PD and constipation.
Study NCT05234034 — intervention group
Intervention type: OTHER
Intervention: online survey
Description: participantion consists of filling in an online survey that will take approximately 53 minutes. An adapted battery of questionnaires is provided for each subgroup.
Study NCT06254235 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: The test octreotide microsphere
Description: A single intramuscular dose of the test octreotide microsphere 30mg,
Study NCT06254235 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: The reference octreotide microsphere
Description: A single intramuscular dose of the reference octreotide microsphere 30mg
Study NCT06044272 — intervention group
Intervention type: OTHER
Intervention: Factors associated
Description: Factors associated with the type of resistance by microorganisms.
Study NCT05017025 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aurora A Kinase Inhibitor LY3295668
Description: Given PO
Study NCT05017025 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osimertinib
Description: Given PO
Study NCT05255250 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PLAYshop
Description: The intervention includes: 1. Educational Training - the 60 min virtual workshop will be delivered by a trained facilitator. Parents will be introduced to physical literacy via education, group discussion, and active participation in fundamental movement skills (FMS) based activities with their child. 2. Distribution of Education Resources- Parents will be sent physical literacy and physical activity printed resources. 3. Material resources -parents will also be provided a bag of inexpensive active play equipment (e.g., ball, bean bag, balloons). 4. Provide Follow-up Support- After the workshop, participants will gain access to an app with an online toolkit including new active play ideas, tips, and equipment they can make at home for active play. Additionally, participants will receive four bi-weekly booster lessons that include key workshop messages, support and encouragement for parents, reflection and check-in questions, and new activities to try with their child.
Study NCT06394466 — intervention group
Intervention type: OTHER
Intervention: Non Applicable
Description: Non Applicable
Study NCT05558813 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cardiac MRI
Description: two cardiac MRIs with Gadolinum injection at 2-year intervals
Study NCT05558813 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood assays
Description: blood samples for the determination of blood biomarkers of heart failure (BNP, NTproBNP) and for the constitution of a biological collection
Study NCT04826497 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nicorandil
Description: All patients received antiplatelet agents (aspirin, ticagrelor) and heparin.Diagnostic coronary angiography (CAG) was performed via the radial artery using the Seldinger method.The guidewire was passed into the culprit lesion.If the blood flow of culprit vessel reaches TIMI2-3 after balloon dilatation,6mg nicorandil was then administrated before stent implantation, A minimum 5-min interval occurred between the first and second doses of nicorandil to reduce adverse effects, subsequently , 6mg/h ivgtt. up to 48h after coronary intervention
Study NCT04826497 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo（normal saline）
Description: All patients received antiplatelet agents (aspirin, ticagrelor) and heparin.Diagnostic coronary angiography (CAG) was performed via the radial artery using the Seldinger method.The guidewire was passed into the culprit lesion.If the blood flow of culprit vessel reaches TIMI2-3 after balloon dilatation,6mg placebo was then administrated before stent implantation, A minimum 5-min interval occurred between the first and second doses of placebo to reduce adverse effects, subsequently , 6mg/h ivgtt. up to 48h after coronary intervention
Study NCT04815473 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Valvulotomy
Description: Valvulotomy of the venous valves
Study NCT05643898 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mamá, te entiendo (Mom, I get you)
Description: Mamá, te entiendo is a guided 8-week cognitive-behavioral app-based intervention that targets postpartum women with minor and major depression. The development of the intervention followed the CeHRes Roadmap. It includes some elements from attachment and mentalization theories.~The intervention consists of six main sequential modules and three optional modules. All modules except the two psychoeducational ones include homework. Participants will receive feedback from an e-coach. They also can contact the e-coach to solve doubts about the app content and exercises. Other sections of the app include infographics about other relevant topics (for example, How to strengthen the couple relationship), a shareable document with reading about how to support a loved one struggling with depression and a resources section with links to websites and documents of interest.
Study NCT04964778 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SKED©
Description: A SKED device is lightweight plastic stretcher used for moving patients through difficult terrain.
Study NCT04780971 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: post-PCI Pd/Pa
Description: After angiographically successful CTO PCI, intra-coronary physiologic assessment (RFR, FFR, CFR and IMR) of the CTO vessel will be performed directly. A staged procedure including several measurements is planned at 4 ± 2 weeks after the index procedure. These measurements consists of the same intra-coronary physiologic assessments at index procedure and OCT imaging of the stented segment in the CTO target vessel.
Study NCT05458154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaires
Description: Participants were recruited from the Baheya Centre for Early Detection and Treatment of Breast Cancer institution. Patients were eligible if they had a previously post-mastectomy pain syndrome (PMPS), and were presented with pain within the surgical area lasting more than 3 months. They were evaluated by questionnaires and methods of pain assessment then received their physiotherapy program specific for pain relief for six sessions, and so re-evaluation. All women gave informed written consent in Arabic and English forms.
Study NCT04857047 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003 2mg
Description: After fasting for at least 10 hours from 10:00 p.m. the previous day, one BR9003 tablet will be administered orally with 150mL of water around 8:30 a.m. after starting breakfast 30 minutes before the scheduled time of administration and finishing it.
Study NCT04857047 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR9003A 1mg
Description: After fasting for at least 10 hours from 10:00 p.m. the previous day, one BR9003A tablet will be administered orally with 150mL of water around 8:30 a.m. after starting breakfast 30 minutes before the scheduled time of administration and finishing it. Another BR9003A tablet will be administered orally with water 150mL around 20:30 after dinner between 18-19:00.
Study NCT04878575 — intervention group
Intervention type: OTHER
Intervention: ASD diagnosis
Description: Autism Diagnostic Interview-revised (ADI-R) and Autism Diagnostic Observation Scale (ADOS)
Study NCT04878575 — intervention group
Intervention type: OTHER
Intervention: Psychiatric diagnosis
Description: Kiddie Schedule for Affective Disorders \& Schizophrenia (K-SADS) for DSM-5
Study NCT04865783 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Saline spray
Description: The saline spray will be applied twice for 1-2 seconds.
Study NCT04865783 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cryospray
Description: The cryospray will be applied twice for 1-2 seconds.
Study NCT06302413 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: They will receive a Virtual Reality Park experience, which is an empty park with no avatars. They will then have a Virtual Reality Avatar experience, where they will see an avatar resembling themselves in a park setting.
Study NCT06302413 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Virtual Reality
Description: They will receive a Virtual Reality Park experience, which is an empty park with no avatars.
Study NCT04033770 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Urodynamic investigation
Description: Urodynamic investigation using an air-charged measurement system
Study NCT04033770 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Urodynamic investigation
Description: Urodynamic investigation using a water-perfused measurement system
Study NCT06416319 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Daily Activity Goal and Feedback
Description: The daily activity target is a fixed number of steps. The exact number of steps is determined beforehand as part of the case number planning in a pilot study with ten participants and adjusted if necessary. The activity target we suggest is 8000 steps. In addition, the participants receive feedback several times a day about the steps needed to reach the goal and whether they have ultimately reached the daily goal.
Study NCT05028946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Foralumab
Description: Foralumab will be administered per dose and schedule specified in the arm description.
Study NCT05527743 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Invasive Physiotherapy
Description: They will receive an invasive physiotherapy protocol of 3 sessions of percutaneous electrolysis and percutaneous neuromodulation guided by ultrasound, with a time margin of one week between the first and the second session and two weeks between the second and the third. Each session will last approximately 30 minutes. Each treatment session will consist of the application of 3 impacts of 3 seconds of 1.5mA intensity (1.5:3:3) (34), in a needle placed in an echoguided manner in the carpal tunnel in relation to the median nerve over the area of fibrosis or entrapment. Subsequently, a second needle will be placed ultrasound-guided at the level of the elbow crease in relation to the median nerve. A symmetric biphasic current with a frequency of 2Hz and a pulse width of 250µs (22,35) will be applied for 17 minutes (36), increasing the intensity of the current until a slight tolerable discomfort is produced in relation to the patient's symptomatology.
Study NCT05527743 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham
Description: The participants of the study corresponding to the sham group will receive the application of the transcutaneous electrical stimulation sham technique (37), placing the patches in the same points where the needles are located in the percutaneous electrolysis and percutaneous neuromodulation technique, remaining in the supine position for the necessary time after the technique is performed, until 30 minutes are completed, thus ensuring that the evaluator does not know to which group each patient has been assigned (37). This technique has been studied as a sham technique for electrolysis and neuromodulation interventions (37).~Once the study is completed and if the results are better in the IF group, the subjects in the sham group will be offered to receive this treatment. The reason for this is to ensure that the entire sample ends up receiving a treatment that, a priori, should improve their functional capacities, thus guaranteeing one of the ethical principles of research.
Study NCT05324007 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Basic Science
Description: This is a basic science experiment to test whether infants' looking time to video stimuli differ according to the race of the individuals shown.